Cargando…
Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p
BACKGROUND: Renal fibrosis is a common outcome of various renal damage, including diabetic nephropathy (DN), the leading cause of end-stage renal disease. Currently, there are no effective therapies for renal fibrosis. The present study aimed to determine whether pentosan polysulphate sodium (PPS),...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925175/ https://www.ncbi.nlm.nih.gov/pubmed/35291969 http://dx.doi.org/10.1186/s12882-022-02732-8 |
_version_ | 1784670014075305984 |
---|---|
author | Xiao, Liangxiang Chen, Anqun Gao, Qing Xu, Bo Guo, Xiaodan Guan, Tianjun |
author_facet | Xiao, Liangxiang Chen, Anqun Gao, Qing Xu, Bo Guo, Xiaodan Guan, Tianjun |
author_sort | Xiao, Liangxiang |
collection | PubMed |
description | BACKGROUND: Renal fibrosis is a common outcome of various renal damage, including diabetic nephropathy (DN), the leading cause of end-stage renal disease. Currently, there are no effective therapies for renal fibrosis. The present study aimed to determine whether pentosan polysulphate sodium (PPS), a FDA approved medication for interstitial cystitis, protects diabetic renal fibrosis. METHODS: Cell viability and apoptosis were evaluated in mouse mesangial cells (SV40-MES13) after incubating with the advanced glycation end products (AGEs), which play important roles in the pathogenesis of DN. Western blot and ELISA were performed to determine the expression of transforming growth factor-beta1 (TGF-β1) and fibronectin (FN), two biomarkers of renal fibrosis, as well as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα), two biomarkers of inflammation. The miRNA-mRNA regulatory network involved in the phosphatidylinositol 3-kinase (PI3K)/Ser and Thr Kinase (AKT) signalling was investigated by miRNA deep sequencing and validated by RT-PCR and miRNA transfection. RESULTS: AGEs significantly inhibited cell proliferation and promoted cell apoptosis, which was associated with the overexpression of TGF-β1, FN, IL-6, and TNFα. PPS almost completely reversed AGEs-induced biomarkers of fibrosis and inflammation, and significantly altered the miRNA expression profile in AGEs-treated cells. Notably, the PI3K/AKT signalling was one of the most significantly enriched pathways targeted by PPS-related differentially expressed miRNAs. PPS significantly up-regulated miR-466a-3p, which was shown to target PIK3CA, and mediated the inhibitory effect of PPS on AGEs-induced activation of PI3K/AKT pathway. CONCLUSIONS: The treatment of PPS protected against AGEs-induced toxicity in SV40 MES13 cells via miR-466a-3p-mediated inhibition of PI3K/AKT pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-02732-8. |
format | Online Article Text |
id | pubmed-8925175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89251752022-03-23 Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p Xiao, Liangxiang Chen, Anqun Gao, Qing Xu, Bo Guo, Xiaodan Guan, Tianjun BMC Nephrol Research BACKGROUND: Renal fibrosis is a common outcome of various renal damage, including diabetic nephropathy (DN), the leading cause of end-stage renal disease. Currently, there are no effective therapies for renal fibrosis. The present study aimed to determine whether pentosan polysulphate sodium (PPS), a FDA approved medication for interstitial cystitis, protects diabetic renal fibrosis. METHODS: Cell viability and apoptosis were evaluated in mouse mesangial cells (SV40-MES13) after incubating with the advanced glycation end products (AGEs), which play important roles in the pathogenesis of DN. Western blot and ELISA were performed to determine the expression of transforming growth factor-beta1 (TGF-β1) and fibronectin (FN), two biomarkers of renal fibrosis, as well as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα), two biomarkers of inflammation. The miRNA-mRNA regulatory network involved in the phosphatidylinositol 3-kinase (PI3K)/Ser and Thr Kinase (AKT) signalling was investigated by miRNA deep sequencing and validated by RT-PCR and miRNA transfection. RESULTS: AGEs significantly inhibited cell proliferation and promoted cell apoptosis, which was associated with the overexpression of TGF-β1, FN, IL-6, and TNFα. PPS almost completely reversed AGEs-induced biomarkers of fibrosis and inflammation, and significantly altered the miRNA expression profile in AGEs-treated cells. Notably, the PI3K/AKT signalling was one of the most significantly enriched pathways targeted by PPS-related differentially expressed miRNAs. PPS significantly up-regulated miR-466a-3p, which was shown to target PIK3CA, and mediated the inhibitory effect of PPS on AGEs-induced activation of PI3K/AKT pathway. CONCLUSIONS: The treatment of PPS protected against AGEs-induced toxicity in SV40 MES13 cells via miR-466a-3p-mediated inhibition of PI3K/AKT pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-02732-8. BioMed Central 2022-03-15 /pmc/articles/PMC8925175/ /pubmed/35291969 http://dx.doi.org/10.1186/s12882-022-02732-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Xiao, Liangxiang Chen, Anqun Gao, Qing Xu, Bo Guo, Xiaodan Guan, Tianjun Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p |
title | Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p |
title_full | Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p |
title_fullStr | Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p |
title_full_unstemmed | Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p |
title_short | Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p |
title_sort | pentosan polysulfate ameliorates fibrosis and inflammation markers in sv40 mes13 cells by suppressing activation of pi3k/akt pathway via mir-446a-3p |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925175/ https://www.ncbi.nlm.nih.gov/pubmed/35291969 http://dx.doi.org/10.1186/s12882-022-02732-8 |
work_keys_str_mv | AT xiaoliangxiang pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p AT chenanqun pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p AT gaoqing pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p AT xubo pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p AT guoxiaodan pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p AT guantianjun pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p |